DayTwo logo

DayTwo Funding & Investors

Walnut Creek, CA

DayTwo is a precision nutrition company that uses food as medicine to enable a path to remission for metabolic diseases including diabetes, prediabetes, clinical obesity, NAFLD. DayTwo's groundbreaking scientific discovery, published in CELL (2015) and JAMA (2019) determined that people respond differently to the same food, thus knowing what food “works” for each person is crucial to an effective care plan. DayTwo uses gut microbiome sequencing (stool sample, akin to Cologuard) to create Food Prescriptions™ for each patient which balance blood sugar levels, improve energy, manage hunger, and help members lose weight. The DayTwo virtual care solution is delivered through Certified Diabetes Care and Education Specialists and Registered Dietitians using a digital app to track progress and to communicate with members. DayTwo uses A1C and Time In Range as the primary clinical outcomes, and weight as a secondary outcome. For those who implement the DayTwo protocol, DayTwo offers up to 100% fees-at-risk.

daytwo.com

Total Amount Raised:

DayTwo Funding Rounds

  • Series B

    37,414,821 GBP

    Series B Investors

    Jacky Abitbol
    Yair Schindel
    Poalim Equity
    Volta Circle
    Cathay Innovation
    Micron Technology
    aMoon Fund
    10D
    La Maison Partners
  • Series B

    $5,000,000

    Series B Investors

    Longliv Ventures
    Cathay Innovation
    Samsung Next
  • Series B

    $31,000,000

    Series B Investors

    10D
    aMoon Fund
    Omri Casspi
    Johnson & Johnson
    Seventure Partners
    Samsung Next
    Longliv Ventures
    Cathay Innovation
  • Series A

    $12,000,000

    Series A Investors

    Johnson & Johnson
    Marius Nacht
    Mayo Clinic
    French Investment Fund
    Seventure Partners
    Century Partners
  • Seed

    $5,000,000

Funding info provided by Diffbot.